New breathing machine approach aims to shield heart in lung failure patients

NCT ID NCT07490925

Recruiting now Disease control Sponsor: Beijing Chao Yang Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This study tests a breathing machine strategy that adjusts pressure based on lung measurements to protect the right side of the heart in 180 adults with moderate to severe lung failure from pneumonia. The goal is to see if this method reduces heart strain and complications compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transpulmonary pressure-guided mechanical ventilation (breathing machine strategy)
What this could lead to: If it works, this could reduce heart complications and improve outcomes for patients with severe pneumonia-related lung failure.
What could go wrong: This is an early-stage trial with 180 participants, so results may not apply to all patients. The strategy is complex and may not outperform standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARDS (MODERATE OR SEVERE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome follicular lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARDS (MODERATE OR SEVERE)

Contacts and locations

Locations

Beijing Chao-Yang Hospital
RECRUITING

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.